Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Two vaccines for HPV prove effective in clinical trials

Oct. 31, 2001

Sankyo presents new inhibitors of macrophage activity

Oct. 24, 2001

Antex concludes Phase I of SBIR grant from U.S. Army

Oct. 23, 2001

Oxamide-based inhibitors of IMPDH under study at Roche

Oct. 11, 2001

Xenova terminates TA-HSV development, DISC-PRO studies continue

Oct. 11, 2001

ABX-CBL promising for the management of GVHD according to phase II trial

Oct. 9, 2001

Good stability, favorable pharmacokinetics determined for LJP-920

Oct. 3, 2001

Enrollment completed for phase I/II StreptAvax trial

Sep. 28, 2001

Potential therapy for GVHD continues in late-stage clinical development

Sep. 27, 2001

Second orphan drug designation received for orBec in GVHD

Sep. 27, 2001

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...